US 7250182
Medicament containing Epimedium extract for treatment of prostatic hyperplasia and prostatitis
granted A61KA61K36/00A61K36/258
Quick answer
US patent 7250182 (Medicament containing Epimedium extract for treatment of prostatic hyperplasia and prostatitis) held by Bright Future Pharmaceutical Laboratories expires Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Bright Future Pharmaceutical Laboratories
- Grant date
- Tue Jul 31 2007 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 26 2027 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 6
- CPC classes
- A61K, A61K36/00, A61K36/258, A61K36/296, A61K36/481